Do You Need a License to Sell Peptides in North Dakota?

There is no single credential called a "peptide license" that a business applies for in North Dakota, which is the source of most of the confusion around this question. What a buyer actually faces is three separate questions: whether the business is registered and permitted to sell anything at all, whether the specific product is classified in a way that pulls it under drug-distribution rules enforced by a state board, and whether the product is sold and labeled strictly for research use rather than human use. Those three have different answers, different agencies behind them, and different consequences if you get them wrong. This article is informational only — it is not legal advice, and every specific below should be confirmed with a North Dakota attorney and the relevant state board before you place an order or list a product.

The three questions hiding inside one

When an operator asks whether a license is required, they are usually collapsing three unrelated regulatory layers into one sentence.

Layer one is ordinary business authority. Any entity selling goods generally needs to be properly formed and registered, and most states require some form of sales and use tax permit for retail transactions. This layer has nothing to do with peptides specifically. It applies the same way it would to a business selling lab reagents, supplements, or equipment. Your accountant and the state's business registration office are the right first call here.

Layer two is product classification. This is where the real work is. Certain categories of product — prescription drugs, controlled substances, and devices among them — carry their own distribution requirements, and states commonly assign oversight of drug wholesaling to a board of pharmacy or an equivalent body. The question you need answered is not "do peptides need a license" but "how is this specific compound, in this specific presentation, classified — and does that classification trigger a distribution permit for my business model?" Two peptides sitting next to each other on a shelf can land in different places.

Layer three is intended use. Research-use-only material is sold, labeled, and marketed for laboratory research. It is not sold for human consumption, and it is not represented as a therapeutic. That distinction is not cosmetic — it shapes how the product is described, who may buy it, and what your business is permitted to say about it. Cross the line in your marketing copy and you may have changed your product's regulatory character without changing anything in the vial.

Ask all three. Answering only the first is how businesses talk themselves into a false sense of clearance.

What research-use-only actually requires of your operation

Operators sometimes read "research use only" as a disclaimer they paste at the bottom of a product page. It is closer to an operating discipline, and it touches parts of the business that have nothing to do with the label.

It means your product listings describe the compound scientifically rather than promising outcomes. It means you are not publishing dosing, administration instructions, or protocol guidance, and you are not implying that a customer will experience a result. It means your customer service scripts, your email flows, your social posts, and any affiliate or influencer content you commission stay inside the same boundary — regulators generally look at the total impression created by your marketing, not just the fine print. And it means your sourcing documentation supports the claim: you should be able to show what you bought, from whom, with what analytical backing.

It also means research peptides are not paired with injection supplies in a way that implies a ready-to-use human kit. If your storefront bundles a compound with bacteriostatic water and syringes, you have effectively told the buyer what you expect them to do with it, regardless of what the disclaimer says.

None of this is a workaround for layer two. Research-use-only framing is not a category that exempts a product from classification questions — it is a description of how a product is sold, and it has to be true in practice.

Questions to bring to your attorney and the state board

Rather than trying to find a published answer that fits your business, bring specific questions to people who can answer them for your facts. A useful starting list:

Two notes on how to use that list. First, get answers in writing where you can — a verbal reading from a phone line is difficult to rely on later. Second, re-ask periodically. Classification and enforcement posture around peptide compounds have been active areas of attention, and an answer that was accurate when you launched may not describe the current landscape. Treat compliance review as a recurring calendar item, not a one-time gate.

Where compound selection changes the conversation

The hardest lesson in this category is that your compliance exposure is largely a function of what you choose to stock. A catalog built around well-characterized research compounds sits in a very different position than one built around whatever is trending.

GLP-1 compounds are the clearest example. Semaglutide, tirzepatide, and retatrutide sit in a regulatory conversation of their own, and they are not part of the Real Peptides wholesale catalog. Melanotan compounds are likewise not offered. If a supplier is willing to quote you on those, that willingness itself is information about how they think about risk — and about what else they might be willing to overlook.

What a research-focused catalog does look like is compounds with published literature behind them and clear analytical characterization. Research suggests peptides such as BPC-157 have been studied for tissue-signaling pathways, and GHK-Cu appears frequently in dermatological and matrix-remodeling literature. Those are statements about where the science is pointing, not promises about what a compound does — and that is exactly the register your own product copy should stay in. Browsing a supplier's popular peptides collection is a reasonable way to see whether their catalog is organized around research categories or around whatever generates the most search volume this quarter.

What a serious supplier should ask you for

A useful test of a wholesale partner is how hard it is to open an account. If a supplier will sell bulk quantities to anyone with a credit card and no questions asked, they are not screening buyers — which means they are also not protecting the reputation of the supply chain you are about to attach your brand to.

Expect to provide business formation documentation, a tax or resale identifier, a description of your business model, and an attestation regarding intended use. Expect the application to be reviewed by a person. Expect some applications to be declined. Friction at this stage is a feature, because the same screening that slows your onboarding is what keeps the supplier's customer base composed of legitimate businesses.

Here is what to verify on the other side of the table before you commit:

What Real Peptides does differently

Real Peptides operates a Wholesale Partner Program built for businesses that have to answer the questions above — med spas, clinics, wellness centers, telehealth companies, and resellers building their own brands.

Compounds are produced to 99%+ HPLC purity and undergo multi-panel batch testing that goes beyond a purity read alone. Certificates of analysis are publicly verifiable rather than gated: a prospective partner can inspect lab results before applying, without a sales call and without paying for documentation that should have been included in the first place. That matters because a COA you cannot see is not evidence — it is a claim about evidence.

Fulfillment runs from within the United States, with orders typically shipping in five to seven days, so inventory planning does not depend on international customs timelines. And the application is three steps: submit your business details, complete verification, and receive tier pricing. Wholesale pricing is structured rather than negotiated case by case, which means you can model your catalog economics before you commit rather than after.

Every compound is supplied for laboratory research use only. Real Peptides does not supply products for human consumption, does not provide dosing or administration guidance, and does not make therapeutic claims — and expects partners to hold the same line in their own marketing.

Where to go from here

If you have confirmed your business registration position, had counsel review how the specific compounds you intend to carry are classified, and set up your product copy to stay inside research-use-only framing, the remaining question is who supplies you. That is the point at which a wholesale application makes sense. Bring your entity documentation and tax identifier, and expect to describe your business model honestly — the verification step exists to keep the partner base composed of operators who have done the same homework you have.

For more on how these requirements are structured across states, see the overview of do you need a license to sell peptides, review pricing and account terms in the wholesale peptides program, or apply for a wholesale account when your compliance review is complete.